Sector
PharmaceuticalsOpen
₹33.83Prev. Close
₹34Turnover(Lac.)
₹0.05Day's High
₹33.83Day's Low
₹32.352 Week's High
₹64.7552 Week's Low
₹23.6Book Value
₹6.58Face Value
₹10Mkt Cap (₹ Cr.)
22.06P/E
0EPS
0Divi. Yield
030 Aug 2024
12:00 AM
AGM
Announcement Date: 30 Aug, 2024
23 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.83 | 6.83 | 6.83 | 6.83 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.47 | 3.98 | 5.23 | 6.83 |
Net Worth | 10.3 | 10.81 | 12.06 | 13.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 19.89 | 24.45 | 20.17 | 14.35 |
yoy growth (%) | -18.64 | 21.18 | 40.52 | -33.54 |
Raw materials | -14.57 | -17.79 | -10.85 | -6.73 |
As % of sales | 73.27 | 72.76 | 53.78 | 46.88 |
Employee costs | -1.49 | -1.58 | -1.81 | -1.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.47 | 0.96 | 0.67 | 0.26 |
Depreciation | -0.34 | -0.39 | -0.46 | -0.44 |
Tax paid | -0.16 | -0.42 | -0.1 | -0.1 |
Working capital | 0.19 | 2.02 | 0.06 | 0.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -18.64 | 21.18 | 40.52 | -33.54 |
Op profit growth | -107.56 | 24.37 | 397.72 | -39.1 |
EBIT growth | -50.83 | 38.23 | 162.62 | 7.53 |
Net profit growth | -42.2 | -5.76 | 252.55 | 289.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Vinay Ramakant Sapte
Non Executive Director
Maneesh R Sapte
Whole-time Director
Y N Bhaskara Rao
Non Executive Director
Rashmi V Sapte
Independent Director
PRAVIN M. HEGDE
Independent Director
Ajit G Jamkhandikar
Company Sec. & Compli. Officer
Urvashi Bhatia
16 Phase III,
I D A Jeedimetla,
Telangana - 500055
Tel: 91-40-23095002/23095690
Website: http://www.phaarmasia.in
Email: phaarmasiagrd@gmail.com
6-2-913/914 3rd Flr,
Progressive Towers, Khairtabad,
Hyderabad - 500 004
Tel: 91-40-3324804/332226
Website: -
Email: info@vccilindia.com
Summary
Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was establishe...
Read More
Reports by Phaarmasia Ltd
What is the Phaarmasia Ltd share price today?
What is the Market Cap of Phaarmasia Ltd?
What is the PE and PB ratio of Phaarmasia Ltd?
What is the 52 Week High and Low of Phaarmasia Ltd?
What is the CAGR of Phaarmasia Ltd?
What is the shareholding pattern of Phaarmasia Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.